Jaclyn Reports Third Quarter Financial Results MAYWOOD,

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Jaclyn Reports Third Quarter Financial Results

MAYWOOD, NJ--(Marketwired - Jan 11, 2016) - Jaclyn, Inc. (OTCQX: JCLY) today reported financial results for the third quarter ended November 30, 2015.

Net sales for the three-month period ended November 30, 2015 were $42,642,000 compared to $44,860,000 for the three-month period ended November 30, 2014. The Company reported third quarter ended November 30, 2015 net earnings of $242,000, or $.11 per diluted share, compared to net earnings in last year's third quarter of $573,000, or $.25 per diluted share.

Net sales for the nine-month period ended November 30, 2015 were $123,078,000 compared to $119,441,000 for the same period last year. Net earnings for the nine-month period ended November 30, 2015 were $155,000, or $.07 per diluted share. This compares to net earnings of $145,000, or $.06 per diluted share, in the comparable nine-month period last year.

Note: This press release contains information concerning, among other things, our future plans and objectives that is or may be deemed to be forward-looking statements. However, forward-looking statements are subject to a number of known and unknown risks and uncertainties that may cause our actual results, trends, performance or achievements, or industry trends and results, to differ materially from the future results, trends, performance or achievements expressed or implied by such forward-looking statements. Those risks and uncertainties may include, but are not limited to, general economic and business conditions; competition; potential changes in customer spending; acceptance of our product offerings and designs; the variability of consumer spending resulting from changes in domestic economic activity; a highly promotional retail environment; any significant variations between actual amounts and the amounts estimated for those matters identified as our critical accounting estimates as well as other significant accounting estimates made in the preparation of our financial statements; and the impact of current and potential hostilities in various parts of the world; as well as other geopolitical concerns. You are urged to consider all such factors. In light of the uncertainty inherent in such forward-looking statements, you should not consider their inclusion to be a representation that such forward-looking matters will be achieved. We assume no obligation for updating any such forward-looking statements to reflect actual results, changes in assumptions or changes in other factors affecting such forward-looking statements.

Jaclyn, Inc. is a designer, manufacturer and marketer of apparel, women's sleepwear, infants' and children's apparel, handbags, premium incentives and related accessories. Website: jaclyninc.com.

 
JACLYN, INC. AND SUBSIDIARIES
 
CONDENSED CONSOLIDATED STATEMENTS OF EARNINGS (Unaudited)
 
    Third Quarter   Nine Months
    Ended November 30,   Ended November 30,
                 
    2015   2014   2015   2014
                 
Net Sales   $ 42,642,000   $ 44,860,000   $ 123,078,000   $ 119,441,000
                         
Net Earnings   $ 242,000   $ 573,000   $ 155,000   $ 145,000
                         
Net Earnings per Common Share - Diluted   $ .11   $ .25   $ .07   $ .06
                         
Weighted Average Number of Shares Outstanding - Diluted     2,280,000     2,280,000     2,280,000     2,280,000
                           

Company Contact: Anthony Christon Chief Financial Officer Jaclyn, Inc. (201) 909-6000

Scroll down for more posts ▼

Top 10 Most Recent News Articles

BioVid Debuts AI to Mimic Physician Decision-Making

Updated Category News Views 47

Revolutionizing Understanding: BioVid Mimetics™ Now here's something that's shaking the research tree: BioVid's launching Mimetics™, and it's a big deal. They've come up with AI that can mirror how physicians think and decide. This ain't your run-of-the-mill tech stuff—it's groundbreaking in understanding physician decision-making. The Core: How Do Doctors Really...

Continue Reading
Acqualina Resort's Sustainable Commitment Earns Praise

Updated Category News Views 52

Sustainability at the Heart of Luxury Spotlight's on Acqualina Resort again. The folks there have snagged the 2026 VERIFIED™ Responsible Hospitality badge from Forbes Travel Guide for the third straight year. Means they’re more than just a pretty face down in Miami. This accolade puts them slap bang among the best in sustainable luxury. Forbes doesn’t just hand...

Continue Reading
Divorce Expertise: Obenhaus Adds CDFA Credential

Updated Category News Views 84

Divorce isn't just a legal tangled mess; it's a financial minefield as well. Lindsey Obenhaus from Goranson Bain Ausley has beefed up her credentials with a Certified Divorce Financial Analyst® (CDFA®) designation, lending a sharper edge to her approach in divorce financials. When relationships turn sour, so do wallets, and Obenhaus aims to soften that blow for her...

Continue Reading
Howard Hughes Joins S&P SmallCap 600, Arcosa Out

Updated Category News Views 45

Shakeup in the S&P SmallCap 600 It’s one of those days where something shifts in the market landscape—Howard Hughes Holdings Inc. (NYSE: HHH) is swaggering into the S&P SmallCap 600. Kicking off on October 28, it's got quite the entrance lined up. On the other end, Arcosa Inc. (NYSE: ACA) is making a hasty exit after getting scooped up by CRH plc (NYSE: CRH). For...

Continue Reading
Darden Faces Class Action Over Reimbursement Failures

Updated Category News Views 15

Class Action Puts Darden Restaurants in Legal Hot Seat Darden Restaurants, Inc. is staring down the barrel of a lawsuit that's as fiery as a grill on a Saturday night rush. The legal cavalry from Blumenthal Nordrehaug Bhowmik De Blouw LLP has stormed in with a class action complaint, aiming dead center at Darden for allegedly breaching the California Labor Code. In plain...

Continue Reading
Amy Johnson Steps Up as GDIT President Amid Shifts

Updated Category News Views 68

A New Chapter for GDIT with a Veteran Leader Big shoes to fill? Nah, more like Amy Johnson was made for these shoes. Stepping up as president of General Dynamics Information Technology (GDIT) on November 3, she’s got 27 years of experience under her belt, all from General Dynamics' own backyard. This ain't her first rodeo. From tightrope-walking the perils of defense...

Continue Reading
Taiwan Fuses Ancient TCM with Modern Bio Tech in 2026

Updated Category News Views 40

The Dynamic Fusion of Heritage and Innovation When you think about it, mixing centuries-old herbal wisdom with today's cutting-edge biotech might sound like a plot twist, but that's exactly what's cooking in Taiwan. Over at SupplySide Global 2026 in Las Vegas, Taiwan's got something more than just traditional medicine to flaunt; it's showcasing an impressive fusion of...

Continue Reading
Think Together Marks 20 Years of ASES Impact in CA

Updated Category News Views 64

Hands-on Learning: California's Bright Future Starts Here Who's ever thought a schoolyard's the same after three? Let me tell you, in California, it's staying alive and kicking, thanks to Think Together's whirlwind of celebrations for the After School Education and Safety (ASES) program. We're talking 450 schoolyard shindigs highlighting not just how far expanded learning...

Continue Reading
University of Phoenix Unveils Credit for Prior Learning Advantages

Updated Category News Views 27

Navigating College Credits with Life Experience If you think school is the only place to pick up education that counts, think again. University of Phoenix is challenging this by recognizing the value of the hustle and grind working adults go through. During the recently wrapped-up National Transfer Student Week, Devin Andrews, their VP of Admissions and Evaluation, shed...

Continue Reading
Amgen's IMDELLTRA® Shows Promise in SCLC Battle

Updated Category News Views 142

Breakthrough Results in SCLC Treatment For years, small cell lung cancer (SCLC) has been the unruly beast in the oncology world, defying treatment advances and keeping survival rates stubbornly low. This nasty foe might just have met its match, folks. Amgen (NASDAQ:AMGN) announced results from their Phase 3 DeLLphi-305 trial that show their drug IMDELLTRA®, when teamed...

Continue Reading

Top 5 Most Recently Viewed Articles

VERSES AI Secures Major Contract with Global Investment Firm

Updated Category News Views 183

Strategic Move by VERSES AI VERSES AI Inc. has made an impressive leap in the cognitive computing sector by securing a contract with a leading global investment firm. This partnership is rooted in the recent success of the company's Genius beta program, where initial evaluations highlighted the platform's remarkable capabilities. Enterprise Agreement Details As part of...

Continue Reading
Expected Growth of Agricultural Adjuvants Market to USD 6.2B

Updated Category News Views 143

The Agricultural Adjuvants Market: An Overview The Agricultural Adjuvants Market is witnessing remarkable growth as demand for crop protection products increases. Recent studies estimate that the market, valued at around USD 3.9 billion, is projected to reach approximately USD 6.2 billion by 2034. This translates to a compound annual growth rate (CAGR) of about 4.78% from...

Continue Reading
Understanding CVS Health Inc.'s P/E Ratio in Depth

Updated Category News Views 428

Analyzing the Price-to-Earnings Ratio of CVS Health Inc. In the current trading session, CVS Health Inc. (NYSE: CVS) is trading at a price of $79.86, experiencing a slight decrease of 0.01%. Over the past month, the stock has shown a decline of about 0.99%. However, looking back over the last year, the company's stock has seen a remarkable increase of 44.98%. This...

Continue Reading
Lead the Charge: Edwards Lifesciences Shareholders Unite

Updated Category News Views 138

Understanding the Class Action for Edwards Lifesciences Investors If you are an investor in Edwards Lifesciences Corporation (NYSE: EW), it is crucial to be aware of your rights and options, especially in the wake of substantial losses. Recent developments have opened the door for investors to come together and pursue a collective legal approach toward holding the company...

Continue Reading
Johnson Fistel Investigates Centuri's Stock Price Decline

Updated Category News Views 46

Investigating Centuri Holdings, Inc. Johnson Fistel, LLP, a well-regarded shareholder rights law firm, has initiated an investigation into Centuri Holdings, Inc. (NYSE: CTRI) following a noteworthy decline in the company’s stock price. The firm is examining whether there were any violations of securities laws by the company's executives who may have misrepresented or...

Continue Reading